InDex Pharmaceuticals
4 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| The Efficacy and Safety of Cobitolimod in Participants With Moderate to Severe Active Left-Sided Ulcerative Colitis (NCT04985968) | InDex Pharmaceuticals | 2021-11-24 |
| Pharmacokinetics of Cobitolimod Enemas in Participants With Active Ulcerative Colitis (NCT05404074) | InDex Pharmaceuticals | 2021-11-22 |
| The Efficacy of Cobitolimod in Patients With Moderate to Severe Active Ulcerative Colitis (NCT03178669) | InDex Pharmaceuticals | 2017-06-21 |
| The Efficacy and Safety of Cobitolimod (Kappaproct®) in Chronic Active Treatment Refractory Ulcerative Colitis Patients (NCT01493960) | InDex Pharmaceuticals | 2011-12-01 |
Track InDex Pharmaceuticals automatically
Every clearance here is in the API, with alerts when new ones post.